Literature DB >> 18597263

Balanced nutrient fortification enables high-density hybridoma cell culture in batch culture.

E C Jo1, H J Park, J M Park, K H Kim.   

Abstract

Cells of an in vitro culture system are not the same as for an in vivo system, metabolically and physiologically; ineffective utilization of nutrients occurs by cells in vitro. Therefore, a simpler approach is needed to examine closely and overcome differences between in vivo and in vitro cells.Recognizing the ineffectiveness of nutrient utilization in vitro, we have constructed, a balanced, fortified high-density medium based on RPMI 1640 medium previously optimized for relatively low-density cell culture. The high-density medium was used to cultivate a hybridoma line in a batch spinner flask culture. In this fortified medium, a hybridoma cell line 2c3.1 was cultivated to near 1 x 10(7) cells/mL in batch suspension culture. During the culture, glucose, glutamine, and 10 essential amino acids of concentrations five times richer than normal in the medium were almost thoroughly consumed. Combined analysis of these consumption profiles reveals that the balanced, fortified nutrient supply contributes much to cellular activity to overcome the limitations of in vitro cellular growth. Intermediate metabolites, such as ammonium ion and lactic acid, were produced over concentrations reported until now to be inhibitory. This observation suggests that the major conclusive factor against cellular growth over the critical cell density is not so-called inhibitory metabolites. As a result of the high-density culture, 5-8 times higher production of a monoclonal antibody for hepatitis B surface antigen (anti-HBs) was obtained.Active cellular consumption of all the essential nutrients and the corresponding production of MAb strongly support the potential of our approach to overcome the growth limitation of cells in vitro and to obtain high-density hybridoma cell culture.

Entities:  

Year:  1990        PMID: 18597263     DOI: 10.1002/bit.260360709

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  9 in total

1.  Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium: effect of nutrient concentration.

Authors:  F Franĕk; J Dolníková
Journal:  Cytotechnology       Date:  1991-09       Impact factor: 2.058

2.  A comparison of simple growth vessels and a specially designed bioreactor for the cultivation of hybridoma cells.

Authors:  B Persson; C Emborg
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  Growth study of lactate and ammonia double-resistant clones of HL-60 cells.

Authors:  B Schumpp; E J Schlaeger
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

4.  Amino acid metabolism during batch culture of a murine hybridoma, AFP-27.

Authors:  C P Marquis; J P Barford; C Harbour
Journal:  Cytotechnology       Date:  1996-06       Impact factor: 2.058

5.  The role of vitamins and amino acids on hybridoma growth and monoclonal antibody production.

Authors:  P Ducommun; P A Ruffieux; U von Stockar; I Marison
Journal:  Cytotechnology       Date:  2001-10       Impact factor: 2.058

6.  Development of optimal medium for production of commercially important monoclonal antibody 520C9 by hybridoma cell.

Authors:  Sucharita Sen; Pradip K Roychoudhury
Journal:  Cytotechnology       Date:  2012-07-19       Impact factor: 2.058

7.  Production of monoclonal antibodies against human chorionic gonadotropin by hybridoma cultures in calcium alginate capsules.

Authors:  D J Oh; S K Choi; H N Chang; T B Choe
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

8.  Carbohydrate and amino acid metabolism during batch culture of a human lymphoblastoid cell line, BTSN6.

Authors:  C P Marquis; J P Barford; C Harbour; A Fletcher
Journal:  Cytotechnology       Date:  1996-06       Impact factor: 2.058

9.  The enhancement of specific antibody production rate in glucose- and glutamine-controlled fed-batch culture.

Authors:  T Omasa; M Ishimoto; K Higashiyama; S Shioya; K Suga
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.